Seeking Alpha
2023-04-11 16:02:39

Hot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA falls

The major market averages are neutral during Tuesday's intraday trading as investors wait for this week's important inflation data release, which will indicate how quickly interest rates will rise in the future. In terms of specific stocks, Pricesmart ( NASDAQ: PSMT ) advanced on strong results news while Tilray ( NASDAQ: TLRY ) declined on Q3 sales disappointment. Elsewhere, Coinbase ( NASDAQ: COIN ), Marathon Digital ( NASDAQ: MARA ), MicroStrategy ( NASDAQ: MSTR ) and RIOT ( NASDAQ: RIOT ) led a rally in crypto-focused stocks as the Bitcoin ( BTC-USD ) crossed the $30K threshold. Meanwhile, TG Therapeutics ( NASDAQ: TGTX ) rose to a 52-week high on B. Riley's comments, while Moderna ( NASDAQ: MRNA ) fell as its flu vaccine mRNA-1010 failed to satisfy an early success benchmark. Gainers PriceSmart ( PSMT ) rose more than 10% after beating the expected mark in Q2 with a sales increase of around 10%. Shares of TG Therapeutics ( TGTX ) rose 17% to a new 52-week high after B. Riley Securities reported an increasing trend in demand for the company's recently authorised multiple sclerosis medication Briumvi. Meanwhile, crypto-linked stocks Coinbase ( COIN ) +7.4% , Marathon Digital ( MARA ) +9% , Riot Platforms ( RIOT ) +12.7% , MicroStrategy ( MSTR ) +6.3% , Hive Blockchain ( NASDAQ: HIVE ) +5.4% , and CleanSpark ( NASDAQ: CLSK ) +10.9% led the recovery in the crypto market, with Bitcoin ( BTC-USD ) surpassing the $30K threshold , maintaining the highest levels seen since June last year, when it last surpassed $30,000. Decliners Tilray ( TLRY ) slumped roughly 8% after announcing lower-than-expected revenue for the third quarter, driven by a 14% year-on-year fall in net cannabis sales to $47.5 million. In addition, the company recorded a gross loss of $11.7 million, compared to a profit of $40 million the previous year. In the meantime, Moderna ( MRNA ) fell more than 5% after its seasonal influenza (flu) vaccine mRNA-1010 failed to accumulate enough cases at an interim effectiveness analysis to announce early success in a Northern Hemisphere phase 3 study. To keep track of Wall Street's biggest winners and losers throughout the session, head over to Seeking Alpha's On The Move section .

Crypto 뉴스 레터 받기
면책 조항 읽기 : 본 웹 사이트, 하이퍼 링크 사이트, 관련 응용 프로그램, 포럼, 블로그, 소셜 미디어 계정 및 기타 플랫폼 (이하 "사이트")에 제공된 모든 콘텐츠는 제 3 자 출처에서 구입 한 일반적인 정보 용입니다. 우리는 정확성과 업데이트 성을 포함하여 우리의 콘텐츠와 관련하여 어떠한 종류의 보증도하지 않습니다. 우리가 제공하는 컨텐츠의 어떤 부분도 금융 조언, 법률 자문 또는 기타 용도에 대한 귀하의 특정 신뢰를위한 다른 형태의 조언을 구성하지 않습니다. 당사 콘텐츠의 사용 또는 의존은 전적으로 귀하의 책임과 재량에 달려 있습니다. 당신은 그들에게 의존하기 전에 우리 자신의 연구를 수행하고, 검토하고, 분석하고, 검증해야합니다. 거래는 큰 손실로 이어질 수있는 매우 위험한 활동이므로 결정을 내리기 전에 재무 고문에게 문의하십시오. 본 사이트의 어떠한 콘텐츠도 모집 또는 제공을 목적으로하지 않습니다.